{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T15:47:02Z","timestamp":1795016822917,"version":"4.10.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T00:00:00Z","timestamp":1641686400000},"content-version":"am","delay-in-days":314,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100015613","name":"Centre hospitalier r\u00e9gional universitaire de Lille","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015613","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.bone.2020.115838","type":"journal-article","created":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T22:05:37Z","timestamp":1609279537000},"page":"115838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Persistence with osteoporosis treatment in patients from the Lille University Hospital Fracture Liaison Service"],"prefix":"10.1016","volume":"144","author":[{"given":"Anthony","family":"Delbar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Pflimlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Delabri\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Ternynck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Chantelot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Puisieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Cortet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Paccou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2020.115838_bb0005","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","author":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy","year":"2001","journal-title":"JAMA."},{"key":"10.1016\/j.bone.2020.115838_bb0010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11657-020-0706-y","article-title":"Fragility fractures in Europe: burden, management and opportunities","volume":"15","author":"Borgstr\u00f6m","year":"2020","journal-title":"Arch Osteoporos."},{"key":"10.1016\/j.bone.2020.115838_bb0015","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1359\/jbmr.2000.15.4.721","article-title":"Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis","volume":"15","author":"Klotzbuecher","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2020.115838_bb0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/ard.2008.092775","article-title":"Clinical subsequent fractures cluster in time after first fractures","volume":"68","author":"van Geel","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bone.2020.115838_bb0025","doi-asserted-by":"crossref","first-page":"513 21","DOI":"10.1001\/jama.2009.50","article-title":"Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women","volume":"301","author":"Bliuc","year":"2009","journal-title":"JAMA."},{"key":"10.1016\/j.bone.2020.115838_bb0030","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S0002-9343(97)90022-X","article-title":"The crippling consequences of fractures and their impact on quality of life","volume":"103","author":"Cooper","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.bone.2020.115838_bb0035","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.injury.2008.03.022","article-title":"Mortality following hip fracture: trends and geographical variations over the last 40 years","volume":"39","author":"Haleem","year":"2008","journal-title":"Injury."},{"key":"10.1016\/j.bone.2020.115838_bb0040","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2020.115838_bb0045","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2020.115838_bb0050","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2020.115838_bb0055","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2020.115838_bb0060","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1808082","article-title":"Fracture prevention with zoledronate in older women with osteopenia","volume":"379","author":"Reid","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bone.2020.115838_bb0065","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/pds.4233","article-title":"The national healthcare system claims databases in France, SNIIRAM and EGB: powerful tools for pharmacoepidemiology","volume":"26","author":"Bezin","year":"2017","journal-title":"Pharmacoepidemiology and drug safety"},{"key":"10.1016\/j.bone.2020.115838_bb0070","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s00198-015-3098-x","article-title":"Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000\u20132010","volume":"26","author":"Klop","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2020.115838_bb0075","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/jbmr.2202","article-title":"Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011","volume":"29","author":"Solomon","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2020.115838_bb0080","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1007\/s00198-015-3185-z","article-title":"Two-year adherence to treatment and associated factors in a Fracture Liaison Service in Spain","volume":"26","author":"Naranjo","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2020.115838_bb0085","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1007\/s00198-011-1638-6","article-title":"Management of osteoporosis in Fracture Liaison Service associated with long-term adherence to treatment","volume":"22","author":"Boudou","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2020.115838_bb0090","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1007\/s00198-014-2774-6","article-title":"Secondary prevention of osteoporotic fractures: evaluation of the Amiens University Hospital\u2019s Fracture Liaison Service between January 2010 and December 2011","volume":"25","author":"Dehamchia-Rehailia","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2020.115838_bb0095","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1007\/s00198-013-2348-z","article-title":"Capture the fracture: a best practice framework and global campaign to break the fragility fracture cycle","volume":"24","author":"\u00c5kesson","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2020.115838_bb0100","doi-asserted-by":"crossref","unstructured":"Axelsson KF, Johansson H, Lundh D, M\u00f6ller M, Lorentzon M. Association between recurrent fracture risk and implementation of Fracture Liaison Services in four Swedish hospitals a cohort study. J Bone Miner Res 2020 Feb 25. doi: https:\/\/doi.org\/10.1002\/jbmr.3990.","DOI":"10.2139\/ssrn.3417882"},{"key":"10.1016\/j.bone.2020.115838_bb0105","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00198-015-3443-0","article-title":"Evidence of effectiveness of a Fracture Liaison Service to reduce the re-fracture rate","volume":"27","author":"Nakayama","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2020.115838_bb0110","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bone.2018.03.018","article-title":"Fracture Liaison Services improve outcomes of patients with osteoporosis-related fractures: a systematic literature review and meta-analysis","volume":"111","author":"Wu","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115838_bb0115","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1007\/s00198-017-4144-7","article-title":"One and two-year persistence with different anti-osteoporosis medications: a retrospective cohort study","volume":"28","author":"Reyes","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2020.115838_bb0120","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00198-019-05228-8","article-title":"Persistence and compliance with osteoporosis therapies among postmenopausal women in the UK Clinical Practice Research Datalink","volume":"31","author":"Morley","year":"2020","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2020.115838_bb0125","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11657-017-0316-5","article-title":"Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United States","volume":"12","author":"Durden","year":"2017","journal-title":"Arch Osteoporos"},{"key":"10.1016\/j.bone.2020.115838_bb0130","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1007\/s00198-019-05104-5","volume":"30","author":"Hiligsmann","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2020.115838_bb0135","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00198-013-2481-8","article-title":"Optimizing fracture prevention: the Fracture Liaison Service, an observational study","volume":"25","author":"Eekman","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2020.115838_bb0140","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s00198-019-05036-0","article-title":"Secondary prevention of osteoporotic fractures: evaluation of the Lille University Hospital\u2019s Fracture Liaison Service between January 2016 and January 2018","volume":"30","author":"Pflimlin","year":"2019","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.bone.2020.115838_bb0145","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","article-title":"FRAXTM and the assessment of fracture probability in men and women from the UK","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporosis Int."},{"key":"10.1016\/j.bone.2020.115838_bb0150","doi-asserted-by":"crossref","unstructured":"Briot K, Roux C, Thomas T, Blain H, Buchon D, Chapurlat R, et al. 2018 update of French recommendations on the management of postmenopausal osteoporosis. Joint Bone Spine. 2018;85:519\u2013530.","DOI":"10.1016\/j.jbspin.2018.02.009"},{"key":"10.1016\/j.bone.2020.115838_bb0155","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis."},{"key":"10.1016\/j.bone.2020.115838_bb0160","first-page":"42","article-title":"Persistence with drug therapy: a practical approach using administrative claims data","volume":"10","author":"Dezii","year":"2001","journal-title":"Manag Care"},{"key":"10.1016\/j.bone.2020.115838_bb0165","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0025-6196(11)61093-8","article-title":"Ryu S,Miller RM, Halbert RJ. Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis","volume":"82","author":"Kothawala","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.bone.2020.115838_bb0170","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.bone.2011.12.021","article-title":"Medication adherence and fracture risk among patients on bisphosphonate therapy in a large United States health plan","volume":"50","author":"Wade","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115838_bb0175","doi-asserted-by":"crossref","DOI":"10.1007\/s11657-019-0633-y","article-title":"Persistence and compliance to osteoporosis therapy in a Fracture Liaison Service: a prospective cohort study","volume":"14","author":"Senay","year":"2019","journal-title":"Arch Osteoporos"},{"key":"10.1016\/j.bone.2020.115838_bb0180","doi-asserted-by":"crossref","unstructured":"Cheng LI, Durden E, Limone B et al. Persistance and compliance with osteroporosis therapies among women in a commercially insured population in the United States. J Manag Care Spec Pharm. 2015;21:824\u201333, 833a.","DOI":"10.18553\/jmcp.2015.21.9.824"},{"key":"10.1016\/j.bone.2020.115838_bb0185","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s00198-011-1881-x","article-title":"Persistence with intravenous zoledronate in elderly patients with osteoporosis","volume":"23","author":"Lee","year":"2012","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.bone.2020.115838_bb0190","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1185\/03007990903538409","article-title":"Adherence and persistence in patients with severe osteoporosis treated with teriparatide","volume":"26","author":"Ziller","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.bone.2020.115838_bb0195","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jbspin.2018.01.005","article-title":"Teriparatide persistence and tolerance in patients with osteoporosis: observational data from clinical practice","volume":"85","author":"Taisne","year":"2018","journal-title":"Joint Bone Spine."},{"key":"10.1016\/j.bone.2020.115838_bb0200","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1007\/s00198-018-4759-3","article-title":"A systematic review of factors affecting medication adherence among patients with osteoporosis","volume":"29","author":"Yeam","year":"2018","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.bone.2020.115838_bb0205","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1007\/s00198-019-04963-2","article-title":"Long-term persistence in patients with osteoporosis receiving denosumab in routine practice: 36-month non-interventional, observational study","volume":"30","author":"Borek","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2020.115838_bb0210","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11657-020-0693-z","article-title":"Best practice framework of Fracture Liaison Services in Spain and their coordination with primary care","volume":"15","author":"Naranjo","year":"2020","journal-title":"Arch Osteoporos."},{"key":"10.1016\/j.bone.2020.115838_bb0215","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00198-013-2610-4","article-title":"Compliance and persistence to oral bisphosphonate therapy following initiation within a secondary fracture prevention program: a randomised controlled trial of specialist vs. non-specialist management","volume":"25","author":"Ganda","year":"2014","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.bone.2020.115838_bb0220","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00198-011-1780-1","article-title":"Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women","volume":"23","author":"Freemantle","year":"2012","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.bone.2020.115838_bb0225","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1007\/s00198-016-3623-6","article-title":"GRAND- 4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab","volume":"27","author":"Hadji","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2020.115838_bb0230","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1007\/s00198-015-3253-4","article-title":"Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis","volume":"26","author":"Karlsson","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2020.115838_bb0235","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00198-019-05228-8","article-title":"Persistence and compliance with osteoporosis therapies among postmenopausal women in the UK Clinical Practice Research Datalink","volume":"31","author":"Morley","year":"2020","journal-title":"Osteoporosis International"},{"key":"10.1016\/j.bone.2020.115838_bb0240","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jbspin.2017.12.013","article-title":"Effects and management of denosumab discontinuation","volume":"85","author":"Chapurlat","year":"2018","journal-title":"Joint Bone Spine."},{"key":"10.1016\/j.bone.2020.115838_bb0245","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00223-018-0409-1","article-title":"Multiple vertebral fractures following denosumab discontinuation: are we exaggerating?","volume":"103","author":"Anastasilakis","year":"2018","journal-title":"Calcif Tissue Int."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220306268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220306268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:54:27Z","timestamp":1757613267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328220306268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":49,"alternative-id":["S8756328220306268"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2020.115838","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistence with osteoporosis treatment in patients from the Lille University Hospital Fracture Liaison Service","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2020.115838","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115838"}}